Glycemic control to improve post-operative outcomes in patients with type 2 diabetes mellitus: Results of the SUGAR (Surgical Universal euGlycemic Attainment during Recovery) initiative.

IF 4.7 2区 医学 Q1 OBSTETRICS & GYNECOLOGY International Journal of Gynecological Cancer Pub Date : 2025-01-01 Epub Date: 2024-12-18 DOI:10.1016/j.ijgc.2024.100003
Jolyn S Taylor, Bryan Fellman, Katherine E Cain, Maria D Iniesta, Terri Earles, Melinda Harris, Deepthi James, Christine Siebel, Javier Lasala, Gabriel Mena, Sally Raty, Shannon Popovich, Khanh Vu, Sonali Thosani, Conor Best, Kathleen M Schmeler, Pedro T Ramirez, Larissa A Meyer
{"title":"Glycemic control to improve post-operative outcomes in patients with type 2 diabetes mellitus: Results of the SUGAR (Surgical Universal euGlycemic Attainment during Recovery) initiative.","authors":"Jolyn S Taylor, Bryan Fellman, Katherine E Cain, Maria D Iniesta, Terri Earles, Melinda Harris, Deepthi James, Christine Siebel, Javier Lasala, Gabriel Mena, Sally Raty, Shannon Popovich, Khanh Vu, Sonali Thosani, Conor Best, Kathleen M Schmeler, Pedro T Ramirez, Larissa A Meyer","doi":"10.1016/j.ijgc.2024.100003","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Hyperglycemia, or glucose values >180 mg/dL, is associated with adverse post-operative outcomes. Our objective was to determine the impact of improving peri-operative glycemic control and evaluate infectious complications among patients with type 2 diabetes mellitus undergoing open gynecologic surgery.</p><p><strong>Methods: </strong>A multidisciplinary team standardized pre-operative screening, referral algorithms, and intra-operative and post-operative hyperglycemia management (Surgical Universal euGlycemic Attainment during Recovery initiative). We compared outcomes between a baseline cohort (March 2016-December 2017) and an intervention cohort (February 2018-August 2022). Patients with type 1 diabetes, and planned minimally invasive, multi-team, or emergency surgery were excluded. Clinical and demographic characteristics were compared using the χ<sup>2</sup> test, Fisher exact test, t test, or Wilcoxon rank-sum test, and generalized linear mixed models were used with a logit link function. All statistical analyses were performed using Stata/MP v17.0 (College Station, StataCorp).</p><p><strong>Results: </strong>We assessed 103 baseline patients and 167 intervention patients with diabetes. In the baseline cohort, 26 patients (25%) had hemoglobin A1C screened prior to surgery compared with 158 (95%) in the intervention cohort (p < .001). All surgical patients were screened for diabetes to determine eligibility, and we tracked the rate of patients newly diagnosed with type 2 diabetes (18 patients or 11%). The percentages of glucose values ≤180 mg/dL pre-operatively or intra-operatively were similar between cohorts, but the intervention cohort had increased compliance with assessing glucose intra-operatively (84% compared with 55%, p < .001). The percentage of post-operative glucose values ≤180 mg/dL increased from 77% in the baseline cohort to 86% in the intervention cohort (p = .002). The average post-operative glucose value was 10 mg/dL lower in the intervention cohort than in the baseline cohort (p = .005). Rates of surgical site infection, pneumonia, and urinary tract infection were similar between cohorts.</p><p><strong>Conclusion: </strong>Our initiative improved compliance with pre-operative glycemic screening and decreased hyperglycemia among diabetic patients. We did not identify the correlation between glycemic control and infectious complications.</p>","PeriodicalId":14097,"journal":{"name":"International Journal of Gynecological Cancer","volume":"35 1","pages":"100003"},"PeriodicalIF":4.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Gynecological Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijgc.2024.100003","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Hyperglycemia, or glucose values >180 mg/dL, is associated with adverse post-operative outcomes. Our objective was to determine the impact of improving peri-operative glycemic control and evaluate infectious complications among patients with type 2 diabetes mellitus undergoing open gynecologic surgery.

Methods: A multidisciplinary team standardized pre-operative screening, referral algorithms, and intra-operative and post-operative hyperglycemia management (Surgical Universal euGlycemic Attainment during Recovery initiative). We compared outcomes between a baseline cohort (March 2016-December 2017) and an intervention cohort (February 2018-August 2022). Patients with type 1 diabetes, and planned minimally invasive, multi-team, or emergency surgery were excluded. Clinical and demographic characteristics were compared using the χ2 test, Fisher exact test, t test, or Wilcoxon rank-sum test, and generalized linear mixed models were used with a logit link function. All statistical analyses were performed using Stata/MP v17.0 (College Station, StataCorp).

Results: We assessed 103 baseline patients and 167 intervention patients with diabetes. In the baseline cohort, 26 patients (25%) had hemoglobin A1C screened prior to surgery compared with 158 (95%) in the intervention cohort (p < .001). All surgical patients were screened for diabetes to determine eligibility, and we tracked the rate of patients newly diagnosed with type 2 diabetes (18 patients or 11%). The percentages of glucose values ≤180 mg/dL pre-operatively or intra-operatively were similar between cohorts, but the intervention cohort had increased compliance with assessing glucose intra-operatively (84% compared with 55%, p < .001). The percentage of post-operative glucose values ≤180 mg/dL increased from 77% in the baseline cohort to 86% in the intervention cohort (p = .002). The average post-operative glucose value was 10 mg/dL lower in the intervention cohort than in the baseline cohort (p = .005). Rates of surgical site infection, pneumonia, and urinary tract infection were similar between cohorts.

Conclusion: Our initiative improved compliance with pre-operative glycemic screening and decreased hyperglycemia among diabetic patients. We did not identify the correlation between glycemic control and infectious complications.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血糖控制改善2型糖尿病患者术后预后:SUGAR(手术恢复期间普遍血糖达标)倡议的结果
目的:高血糖或血糖值> ~ 180mg /dL与术后不良预后相关。我们的目的是确定改善围手术期血糖控制的影响,并评估接受开放式妇科手术的2型糖尿病患者的感染并发症。方法:一个多学科团队标准化术前筛查,转诊算法,术中和术后高血糖管理(外科通用恢复期间血糖达标计划)。我们比较了基线队列(2016年3月- 2017年12月)和干预队列(2018年2月- 2022年8月)的结果。1型糖尿病患者、计划微创、多组手术或急诊手术被排除在外。采用χ2检验、Fisher精确检验、t检验或Wilcoxon秩和检验比较临床和人口学特征,并采用logit关联函数的广义线性混合模型。所有统计分析均使用Stata/MP v17.0 (College Station, StataCorp)进行。结果:我们评估了103名基线患者和167名干预患者。在基线队列中,26例(25%)患者在手术前进行了血红蛋白A1C筛查,而干预队列中有158例(95%)进行了筛查(p < 0.001)。对所有手术患者进行糖尿病筛查以确定其资格,并跟踪新诊断为2型糖尿病患者的比率(18例或11%)。术前或术中血糖值≤180 mg/dL的百分比在队列之间相似,但干预队列对术中血糖评估的依从性增加(84%与55%相比,p < 0.001)。术后血糖值≤180mg /dL的百分比从基线组的77%增加到干预组的86% (p = 0.002)。干预组的平均术后血糖值比基线组低10 mg/dL (p = 0.005)。手术部位感染、肺炎和尿路感染的发生率在队列之间相似。结论:我们的倡议提高了术前血糖筛查的依从性,降低了糖尿病患者的高血糖。我们没有确定血糖控制和感染并发症之间的相关性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.60
自引率
10.40%
发文量
280
审稿时长
3-6 weeks
期刊介绍: The International Journal of Gynecological Cancer, the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach, and includes original research, reviews, and video articles. The audience consists of gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology.
期刊最新文献
Letter in response to correspondence on "Comparative analysis of adjuvant treatment outcomes in stage III endometrial cancer: overall survival, recurrence-free survival, site of primary recurrence, and toxicity" by Fang & Hu. Response to immuno-targeted therapy in recurrent endometrial carcinoma. Clinical behavior of FIGO stage I endometrioid endometrial adenocarcinoma diagnosed as high grade on pre-operative biopsy and low grade on hysterectomy specimen. Avoidance of adjuvant radiotherapy in inter mediate-risk endometrial carcinoma. Challenging the standard in early-stage ovarian cancer: current evidence and a standardized framework for sentinel node mapping.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1